Researching what can be done with the huge quantity of cigarette butts discarded each year is a road well-traveled.Read More
The tobacco debate is being re-heated in London, UK, today with the opening by Philip Morris Limited of a fourth IQOS store in the city.Read More
Canada in dialogue
Tobacco harm reduction will be discussed at a free-to-attend dialogue in Vancouver, a city that is no stranger to the concept of harm reduction.Read More
In no small part because of government policies, the UK vaping industry has had a good 2017, and it is hoping to build on that momentum with a forum next year.Read More
Deadlines have been set for presentations to the US Food and Drug Administration’s committee meeting that will discuss Philip Morris’ modified risk tobacco product applications.Read More
Altria’s Investor Day on November 2 is due to include a morning of presentations followed by a manufacturing-center tour.Read More
With the launch of a third IQOS store in London, Philip Morris is trying to deliver on its pledge to convert 100,000 UK smokers to heated tobacco technology.Read More
The online registration deadlines for CORESTA’s 2017 Joint Study Group meetings are September 27 and October 8.Read More
Will a tobacco tracking and tracing system introduce ‘a mechanism of very little … public health and budgetary benefit which runs counter to all business rationale’?Read More
With its acquisition by Coesia, Molins has joined a stable of companies that includes G.D and Sasib.Read More
Recent Posts
- Robert Kennedy, Jr. Tapped to Lead Trump’s HHS
- Sweden Achieves ‘Smoke Free’ Status
- 22nd Century Net Loss Widens
- Net Sales up at Scandinavian Tobacco
- UKVIA Forum Kicks Off Nov. 15
- Sophisticated Illegal Factory Dismantled in Spain
- Quartz and PCA Launch Dubai Cigar Show
- Stakeholders Mark Start of Brazilian Tobacco Harvest
- Universal Reports Preliminary Results
- Study: Online Retailers Fail to Comply With Rules
- Pyxus International Posts ‘Solid’ Quarter
- Illicit Trade Hurts PTC’s Sales
- Juul Labs Appoints MD
- ‘Switchers’ See Improved Respiratory Health
- Ispire Net Loss Widens to $5.6 Million